United States Pharmaceuticals

SIGA Technologies Inc (SIGA)

Track

SIGA Technologies Inc has recorded no insider trading activity within the last 90 days. The most recent transaction occurred on December 9, 2021, involving a sale of shares. Historical data shows a mix of buying and selling activity by various insiders, with the last recorded trade dating back more than three years.
Ticker: SIGA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for SIGA Technologies Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Antal James
1 sale — total 234,600 USD
Sale 9 Dec 2021
Value US$2,086,471.78 | Price 53.21 | Shares 85,613
Sale 27 Aug 2020
Value US$4,079,343.95 | Price 292.43 | Shares 74,515
Buy 9 Dec 2019
Value US$87,400.00 | Price 4.37 | Shares 20,000
Buy 9 Dec 2019
Value US$10,975.00 | Price 4.39 | Shares 2,500
Buy 9 Dec 2019
Value US$44,200.00 | Price 4.42 | Shares 10,000
Buy 9 Dec 2019
Value US$21,950.00 | Price 4.39 | Shares 5,000
Buy 23 Aug 2019
Value US$49,500.00 | Price 4.95 | Shares 10,000
Buy 9 Aug 2019
Value US$50,800.00 | Price 5.08 | Shares 10,000
Sale 7 Jun 2019
Value US$89,280.00 | Price 5.58 | Shares 16,000
Sale 6 Jun 2019
Value US$94,690.00 | Price 5.57 | Shares 17,000
Sale 5 Jun 2019
Value US$96,560.00 | Price 5.68 | Shares 17,000
Sale 5 Jun 2019
Value US$171,000.00 | Price 5.70 | Shares 30,000
Buy 4 Jun 2019
Value US$71,750.00 | Price 5.74 | Shares 12,500
Buy 16 Nov 2018
Value US$27,900.00 | Price 5.58 | Shares 5,000
Sale 13 Nov 2018
Value US$164,513.71 | Price 5.29 | Shares 31,099
Sale 12 Nov 2018
Value US$93,748.96 | Price 4.96 | Shares 18,901
Buy 12 Nov 2018
Value US$50,100.00 | Price 5.01 | Shares 10,000
Buy 12 Nov 2018
Value US$78,000.00 | Price 5.20 | Shares 15,000
Buy 7 Nov 2014
Value US$196,912.61 | Price 1.52 | Shares 129,727
Buy 6 Nov 2014
Value US$102,207.00 | Price 1.46 | Shares 70,000
Sale 16 Oct 2014
Value US$20,800.40 | Price 1.49 | Shares 13,960
Sale 26 Sep 2014
Value US$33,750.00 | Price 1.35 | Shares 25,000
Buy 24 Sep 2014
Value US$71,914.34 | Price 1.36 | Shares 52,999
Buy 23 Sep 2014
Value US$200,828.52 | Price 1.33 | Shares 151,158
Sale 13 Mar 2014
Value US$47,850.00 | Price 3.19 | Shares 15,000
Buy 17 Sep 2013
Value US$33,473.16 | Price 3.59 | Shares 9,324
Buy 16 Sep 2013
Value US$20,263.32 | Price 3.57 | Shares 5,676
Sale 13 Sep 2013
Value US$11,924.34 | Price 3.53 | Shares 3,378
Sale 12 Sep 2013
Value US$41,258.10 | Price 3.55 | Shares 11,622
Sale 30 May 2013
Value US$57,510.00 | Price 3.83 | Shares 15,000
Buy 24 May 2013
Value US$25,130.00 | Price 3.59 | Shares 7,000
Buy 30 Dec 2011
Value US$122,055.00 | Price 2.44 | Shares 50,000
Buy 29 Sep 2011
Value US$15,100.00 | Price 3.02 | Shares 5,000
Buy 27 Sep 2011
Value US$14,000.00 | Price 2.80 | Shares 5,000
Buy 27 Sep 2011
Value US$28,300.00 | Price 2.83 | Shares 10,000
Buy 27 Sep 2011
Value US$140,000.00 | Price 2.80 | Shares 50,000
Buy 23 Aug 2011
Value US$4,990.00 | Price 4.99 | Shares 1,000
Buy 23 Aug 2011
Value US$2,500.00 | Price 5.00 | Shares 500
Buy 9 Aug 2011
Value US$16,350.00 | Price 5.45 | Shares 3,000
Buy 4 Aug 2011
Value US$62,900.00 | Price 6.29 | Shares 10,000
Buy 4 Aug 2011
Value US$3,654.00 | Price 6.09 | Shares 600
Buy 4 Aug 2011
Value US$8,512.00 | Price 6.08 | Shares 1,400
Buy 15 Jun 2011
Value US$55,300.00 | Price 11.06 | Shares 5,000
Buy 15 Jun 2011
Value US$110,200.00 | Price 11.02 | Shares 10,000
Sale 27 May 2011
Value US$141,500.00 | Price 14.15 | Shares 10,000
Sale 27 May 2011
Value US$424,500.00 | Price 14.15 | Shares 30,000
Sale 23 May 2011
Value US$925,463.00 | Price 13.09 | Shares 70,700
Sale 20 May 2011
Value US$2,539,880.00 | Price 13.51 | Shares 188,000
Sale 19 May 2011
Value US$341,000.00 | Price 13.64 | Shares 25,000
Sale 19 May 2011
Value US$126,090.00 | Price 14.01 | Shares 9,000
Sale 19 May 2011
Value US$563,332.00 | Price 13.64 | Shares 41,300
Sale 19 May 2011
Value US$140,700.00 | Price 14.07 | Shares 10,000
Sale 19 May 2011
Value US$227,738.00 | Price 14.00 | Shares 16,267
Sale 30 Mar 2010
Value US$64,700.00 | Price 6.47 | Shares 10,000
Sale 30 Mar 2010
Value US$377,462.82 | Price 6.51 | Shares 57,982
Sale 29 Mar 2010
Value US$75,130.00 | Price 6.83 | Shares 11,000
Sale 29 Mar 2010
Value US$454,382.04 | Price 6.78 | Shares 67,018
Buy 15 Dec 2009
Value US$24,600.00 | Price 6.00 | Shares 4,100
Buy 15 Dec 2009
Value US$18,000.00 | Price 6.00 | Shares 3,000
Buy 15 Dec 2009
Value US$60,000.00 | Price 6.00 | Shares 10,000
Buy 15 Dec 2009
Value US$5,970.00 | Price 5.97 | Shares 1,000
Sale 1 Dec 2009
Value US$180,200.00 | Price 9.01 | Shares 20,000
Sale 30 Sep 2009
Value US$24,036,286.56 | Price 6.24 | Shares 3,851,969
Sale 30 Sep 2009
Value US$24,036,286.56 | Price 6.24 | Shares 3,851,969
Buy 30 Sep 2009
Value US$24,036,286.56 | Price 6.24 | Shares 3,851,969
Buy 2 Sep 2009
Value US$3,295.00 | Price 6.59 | Shares 500
Buy 2 Sep 2009
Value US$3,290.00 | Price 6.58 | Shares 500
Buy 2 Sep 2009
Value US$3,290.00 | Price 6.58 | Shares 500
Buy 2 Sep 2009
Value US$1,977.00 | Price 6.59 | Shares 300
Buy 2 Sep 2009
Value US$1,316.00 | Price 6.58 | Shares 200
Buy 2 Sep 2009
Value US$3,285.00 | Price 6.57 | Shares 500
Buy 2 Sep 2009
Value US$3,295.00 | Price 6.59 | Shares 500
Buy 2 Sep 2009
Value US$3,954.00 | Price 6.59 | Shares 600
Buy 2 Sep 2009
Value US$6,590.00 | Price 6.59 | Shares 1,000
Buy 2 Sep 2009
Value US$2,636.00 | Price 6.59 | Shares 400
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-10 2021-12-09 S Sale
3.3
Antal James
Non-Executive Director
85,613 -37.2%
53.21
US$2,086,472 		85,613 -37.2% 53.21 US$2,086,472
2020-08-28 2020-08-27 S Sale
3.3
Antal James
Non-Executive Director
74,515 +3.2%
292.43
US$4,079,344 		74,515 +3.2% 292.43 US$4,079,344
2019-12-10 2019-12-09 B Purchase SAVAS PAUL G
36,181 -10.1%
442.71
US$3,470,340 		36,181 -10.1% 442.71 US$3,470,340
2019-12-10 2019-12-09 B Purchase Kane Julie
2,500 +inf%
4.39
US$10,975 		2,500 +inf% 4.39 US$10,975
2019-12-10 2019-12-09 B Purchase Gomez Phillip Louis III

Chief Executive Officer
10,000 +2.1%
4.42
US$44,200 		10,000 +2.1% 4.42 US$44,200
2019-12-10 2019-12-09 B Purchase Luckshire Daniel J

Executive VP & CFO
5,000 +2.3%
4.39
US$21,950 		5,000 +2.3% 4.39 US$21,950
2019-08-26 2019-08-23 B Purchase SAVAS PAUL G
10,000 +3.8%
4.95
US$49,500 		10,000 +3.8% 4.95 US$49,500
2019-08-12 2019-08-09 B Purchase SAVAS PAUL G
10,000 +4.0%
5.08
US$50,800 		10,000 +4.0% 5.08 US$50,800
2019-06-07 2019-06-07 S Sale
2.6
Hruby Dennis E

VP & Chief Scientific Officer
16,000 -9.8%
5.58
US$89,280 		16,000 -9.8% 5.58 US$89,280
2019-06-07 2019-06-06 S Sale
2.6
Hruby Dennis E

VP & Chief Scientific Officer
17,000 -9.4%
5.57
US$94,690 		17,000 -9.4% 5.57 US$94,690
2019-06-07 2019-06-05 S Sale
2.6
Hruby Dennis E

VP & Chief Scientific Officer
17,000 -8.6%
5.68
US$96,560 		17,000 -8.6% 5.68 US$96,560
2019-06-07 2019-06-05 S Sale
3.3
Antal James
30,000 -18.6%
5.70
US$171,000 		30,000 -18.6% 5.70 US$171,000
2019-07-02 2019-06-04 B Purchase
1.4
BAYER MICHAEL J
12,500 +10.4%
5.74
US$71,750 		12,500 +10.4% 5.74 US$71,750
2018-11-19 2018-11-16 B Purchase SAVAS PAUL G
5,000 +2.1%
5.58
US$27,900 		5,000 +2.1% 5.58 US$27,900
2018-11-13 2018-11-13 S Sale Hruby Dennis E

VP & Chief Scientific Officer
31,099 -13.6%
5.29
US$164,514 		31,099 -13.6% 5.29 US$164,514
2018-11-13 2018-11-12 S Sale Hruby Dennis E

VP & Chief Scientific Officer
18,901 -7.6%
4.96
US$93,749 		18,901 -7.6% 4.96 US$93,749
2018-11-13 2018-11-12 B Purchase SAVAS PAUL G
10,000 +4.5%
5.01
US$50,100 		10,000 +4.5% 5.01 US$50,100
2018-11-13 2018-11-12 B Purchase Gomez Phillip Louis III

Chief Executive Officer
15,000 +inf%
5.20
US$78,000 		15,000 +inf% 5.20 US$78,000
2014-11-10 2014-11-07 B Purchase MacAndrews & Forbes Holdings Inc. Non-Executive Director Large shareholder
129,727 +1.0%
1.52
US$196,913 		129,727 +1.0% 1.52 US$196,913
2014-11-10 2014-11-06 B Purchase MacAndrews & Forbes Holdings Inc. Non-Executive Director Large shareholder
70,000 +0.5%
1.46
US$102,207 		70,000 +0.5% 1.46 US$102,207
2019-07-02 2014-10-16 S Sale
1.4
BAYER MICHAEL J
13,960 -10.4%
1.49
US$20,800 		13,960 -10.4% 1.49 US$20,800
2014-09-29 2014-09-26 S Sale SLOVIN BRUCE Non-Executive Director
25,000 -20.8%
1.35
US$33,750 		25,000 -20.8% 1.35 US$33,750
2014-09-25 2014-09-24 B Purchase MacAndrews & Forbes Holdings Inc. Non-Executive Director Large shareholder
52,999 +0.4%
1.36
US$71,914 		52,999 +0.4% 1.36 US$71,914
2014-09-25 2014-09-23 B Purchase MacAndrews & Forbes Holdings Inc. Non-Executive Director Large shareholder
151,158 +1.2%
1.33
US$200,829 		151,158 +1.2% 1.33 US$200,829
2014-03-17 2014-03-13 S Sale WEINER MICHAEL MD Non-Executive Director
15,000 -100.0%
3.19
US$47,850 		15,000 -100.0% 3.19 US$47,850
2013-09-18 2013-09-17 B Purchase BAYER MICHAEL J Non-Executive Director
9,324 +164.3%
3.59
US$33,473 		9,324 +164.3% 3.59 US$33,473
2013-09-18 2013-09-16 B Purchase BAYER MICHAEL J
5,676 +inf%
3.57
US$20,263 		5,676 +inf% 3.57 US$20,263
2013-09-16 2013-09-13 S Sale BAYER MICHAEL J Non-Executive Director
3,378 -100.0%
3.53
US$11,924 		3,378 -100.0% 3.53 US$11,924
2013-09-16 2013-09-12 S Sale BAYER MICHAEL J
11,622 -77.5%
3.55
US$41,258 		11,622 -77.5% 3.55 US$41,258
2013-06-03 2013-05-30 S Sale SLOVIN BRUCE Non-Executive Director
15,000 -12.5%
3.83
US$57,510 		15,000 -12.5% 3.83 US$57,510
2013-05-28 2013-05-24 B Purchase Marshall Joseph W III Non-Executive Director
7,000 +30.4%
3.59
US$25,130 		7,000 +30.4% 3.59 US$25,130
2012-01-04 2011-12-30 B Purchase Bevins William C Non-Executive Director
50,000 +inf%
2.44
US$122,055 		50,000 +inf% 2.44 US$122,055
2011-09-29 2011-09-29 B Purchase Marshall Joseph W III Non-Executive Director
5,000 +166.7%
3.02
US$15,100 		5,000 +166.7% 3.02 US$15,100
2011-09-28 2011-09-27 B Purchase SAVAS PAUL G Non-Executive Director
5,000 +8.8%
2.80
US$14,000 		5,000 +8.8% 2.80 US$14,000
2011-09-28 2011-09-27 B Purchase SAVAS PAUL G Non-Executive Director
10,000 +21.3%
2.83
US$28,300 		10,000 +21.3% 2.83 US$28,300
2011-09-27 2011-09-27 B Purchase SLOVIN BRUCE Non-Executive Director
50,000 +90.9%
2.80
US$140,000 		50,000 +90.9% 2.80 US$140,000
2011-08-24 2011-08-23 B Purchase STERN ANDREW L Non-Executive Director
1,000 +87.0%
4.99
US$4,990 		1,000 +87.0% 4.99 US$4,990
2011-08-24 2011-08-23 B Purchase STERN ANDREW L Non-Executive Director
500 +76.9%
5.00
US$2,500 		500 +76.9% 5.00 US$2,500
2011-08-11 2011-08-09 B Purchase Marshall Joseph W III Non-Executive Director
3,000 +inf%
5.45
US$16,350 		3,000 +inf% 5.45 US$16,350
2011-08-08 2011-08-04 B Purchase SAVAS PAUL G Non-Executive Director
10,000 +27.1%
6.29
US$62,900 		10,000 +27.1% 6.29 US$62,900
2011-08-04 2011-08-04 B Purchase TOWNSEND FRANCES F Non-Executive Director
600 +42.9%
6.09
US$3,654 		600 +42.9% 6.09 US$3,654
2011-08-04 2011-08-04 B Purchase TOWNSEND FRANCES F Non-Executive Director
1,400 +inf%
6.08
US$8,512 		1,400 +inf% 6.08 US$8,512
2011-06-15 2011-06-15 B Purchase SLOVIN BRUCE Non-Executive Director
5,000 +10.0%
11.06
US$55,300 		5,000 +10.0% 11.06 US$55,300
2011-06-15 2011-06-15 B Purchase SLOVIN BRUCE Non-Executive Director
10,000 +25.0%
11.02
US$110,200 		10,000 +25.0% 11.02 US$110,200
2011-05-31 2011-05-27 S Sale WEINER MICHAEL MD Non-Executive Director
10,000 -100.0%
14.15
US$141,500 		10,000 -100.0% 14.15 US$141,500
2011-05-31 2011-05-27 S Sale CONSTANCE THOMAS E Non-Executive Director
30,000 -16.2%
14.15
US$424,500 		30,000 -16.2% 14.15 US$424,500
2011-05-23 2011-05-23 S Sale Hruby Dennis E

Chief Scientific Officer

Officer
70,700 -36.1%
13.09
US$925,463 		70,700 -36.1% 13.09 US$925,463
2011-05-23 2011-05-20 S Sale Hruby Dennis E

Chief Scientific Officer

Officer
188,000 -49.0%
13.51
US$2,539,880 		188,000 -49.0% 13.51 US$2,539,880
2011-05-23 2011-05-19 S Sale Antal James Non-Executive Director
25,000 -69.1%
13.64
US$341,000 		25,000 -69.1% 13.64 US$341,000
2011-05-23 2011-05-19 S Sale WEINER MICHAEL MD Non-Executive Director
9,000 -47.4%
14.01
US$126,090 		9,000 -47.4% 14.01 US$126,090
2011-05-23 2011-05-19 S Sale Hruby Dennis E

Chief Scientific Officer

Officer
41,300 -9.7%
13.64
US$563,332 		41,300 -9.7% 13.64 US$563,332
2011-05-20 2011-05-19 S Sale CONSTANCE THOMAS E Non-Executive Director
10,000 -5.1%
14.07
US$140,700 		10,000 -5.1% 14.07 US$140,700
2011-05-20 2011-05-19 S Sale CONSTANCE THOMAS E Non-Executive Director
16,267 -7.7%
14.00
US$227,738 		16,267 -7.7% 14.00 US$227,738
2010-03-31 2010-03-30 S Sale WEINER MICHAEL MD Non-Executive Director
10,000 -20.4%
6.47
US$64,700 		10,000 -20.4% 6.47 US$64,700
2010-03-31 2010-03-30 S Sale Hruby Dennis E

Chief Scientific Officer

Officer
57,982 -6.8%
6.51
US$377,463 		57,982 -6.8% 6.51 US$377,463
2010-03-31 2010-03-29 S Sale WEINER MICHAEL MD Non-Executive Director
11,000 -18.3%
6.83
US$75,130 		11,000 -18.3% 6.83 US$75,130
2010-03-31 2010-03-29 S Sale Hruby Dennis E

Chief Scientific Officer

Officer
67,018 -7.2%
6.78
US$454,382 		67,018 -7.2% 6.78 US$454,382
2009-12-15 2009-12-15 B Purchase ROSE ERIC A MD

Chief Executive Officer

Executive Director
4,100 +0.3%
6.00
US$24,600 		4,100 +0.3% 6.00 US$24,600
2009-12-15 2009-12-15 B Purchase SAVAS PAUL G Non-Executive Director
10,000 +9.9%
6.00
US$60,000 		10,000 +9.9% 6.00 US$60,000
2009-12-15 2009-12-15 B Purchase Fasman Steven L Non-Executive Director
1,000 +2.2%
5.97
US$5,970 		1,000 +2.2% 5.97 US$5,970
2009-12-15 2009-12-15 B Purchase ROSE ERIC A MD

Chief Executive Officer

Executive Director
3,000 +0.2%
6.00
US$18,000 		3,000 +0.2% 6.00 US$18,000
2009-12-03 2009-12-01 S Sale WEINER MICHAEL MD Non-Executive Director
20,000 -25.0%
9.01
US$180,200 		20,000 -25.0% 9.01 US$180,200
2009-10-02 2009-09-30 S Sale MJALLI ADNAN M M Non-Executive Director Large shareholder
3,851,969 -100.0%
6.24
US$24,036,287 		3,851,969 -100.0% 6.24 US$24,036,287
2009-10-02 2009-09-30 S Sale TRANSTECH PHARMA INC Large shareholder
3,851,969 -100.0%
6.24
US$24,036,287 		3,851,969 -100.0% 6.24 US$24,036,287
2009-10-02 2009-09-30 B Purchase MacAndrews & Forbes Holdings Inc. Large shareholder
3,851,969 +inf%
6.24
US$24,036,287 		3,851,969 +inf% 6.24 US$24,036,287
2009-09-03 2009-09-02 B Purchase SLOVIN BRUCE Non-Executive Director
500 +1.3%
6.59
US$3,295 		500 +1.3% 6.59 US$3,295
2009-09-03 2009-09-02 B Purchase SLOVIN BRUCE Non-Executive Director
500 +1.3%
6.58
US$3,290 		500 +1.3% 6.58 US$3,290
2009-09-03 2009-09-02 B Purchase SLOVIN BRUCE Non-Executive Director
500 +1.3%
6.58
US$3,290 		500 +1.3% 6.58 US$3,290
2009-09-03 2009-09-02 B Purchase SLOVIN BRUCE Non-Executive Director
300 +0.8%
6.59
US$1,977 		300 +0.8% 6.59 US$1,977
2009-09-03 2009-09-02 B Purchase SLOVIN BRUCE Non-Executive Director
200 +0.5%
6.58
US$1,316 		200 +0.5% 6.58 US$1,316
2009-09-03 2009-09-02 B Purchase SLOVIN BRUCE Non-Executive Director
500 +1.3%
6.57
US$3,285 		500 +1.3% 6.57 US$3,285
2009-09-03 2009-09-02 B Purchase SLOVIN BRUCE Non-Executive Director
500 +1.4%
6.59
US$3,295 		500 +1.4% 6.59 US$3,295
2009-09-03 2009-09-02 B Purchase SLOVIN BRUCE Non-Executive Director
600 +1.6%
6.59
US$3,954 		600 +1.6% 6.59 US$3,954
2009-09-03 2009-09-02 B Purchase SLOVIN BRUCE Non-Executive Director
1,000 +2.8%
6.59
US$6,590 		1,000 +2.8% 6.59 US$6,590
2009-09-03 2009-09-02 B Purchase SLOVIN BRUCE Non-Executive Director
400 +1.1%
6.59
US$2,636 		400 +1.1% 6.59 US$2,636
Explore more

More insider trading research around SIGA Technologies Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America